Evidence map›Paper›PMID 38292123›Full record

ArticleJournal of clinical biochemistry and nutrition2024

Background factors of idiopathic peptic ulcers and optimal treatment methods: a multicenter retrospective Japanese study.

Noriyuki Nakajima, Toshihisa Takeuchi, Ryota Hokari, Kazuyuki Narimatsu, Katsunori Iijima, Shigeto Koizumi, Kunio Kasugai, Masahide Ebi, Akihito Nagahara, Tsutomu Takeda and 31 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 2 countries.

Noriyuki NakajimaSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
Toshihisa TakeuchiEndoscopy Centre, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
Ryota HokariDepartment of Internal Medicine, National Defense Medical College, Saitama 359-0042, Japan.
Kazuyuki NarimatsuDepartment of Internal Medicine, National Defense Medical College, Saitama 359-0042, Japan.
Katsunori IijimaDepartment of Gastroenterology and Neurology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Shigeto KoizumiDepartment of Gastroenterology and Neurology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Kunio KasugaiDivision of Gastroenterology, Department of Internal Medicine, Aichi Medical University School of Medicine, Aichi 480-1195, Japan.
Masahide EbiDivision of Gastroenterology, Department of Internal Medicine, Aichi Medical University School of Medicine, Aichi 480-1195, Japan.
Akihito NagaharaDepartment of Gastroenterology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Tsutomu TakedaDepartment of Gastroenterology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Toshihiko TomitaDepartment of Gastroenterology, Faculty of Medicine, Hyogo Medical University, Hyogo 663-8501, Japan.
Shinichiro ShinzakiDepartment of Gastroenterology, Faculty of Medicine, Hyogo Medical University, Hyogo 663-8501, Japan.
Kazuhiro MizukamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Oita 879-5503, Japan.
Kazunari MurakamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Oita 879-5503, Japan.
Nobuaki YagiDepartment of Gastroenterology, Asahi University Hospital, Gifu 500-8523, Japan.
Rieko MukaiDepartment of Gastroenterology, Asahi University Hospital, Gifu 500-8523, Japan.
Toshikatsu OkumuraDivision of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Hokkaido 078-8510, Japan.
Hiroki TanabeDivision of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Hokkaido 078-8510, Japan.
Kazuyuki TanakaDepartment of Gastroenterology, Asahikawa-Kosei General Hospital, Hokkaido 078-8211, Japan.
Junichi IwamotoDepartment of Gastroenterology, Endoscopy Center, Tokyo Medical University Ibaraki Medical Center, Tokyo 300-0395, Japan.
Atsushi IrisawaDepartment of Gastroenterology, Dokkyo Medical University, Tochigi 321-0207, Japan.
Koh FukushiDepartment of Gastroenterology, Dokkyo Medical University, Tochigi 321-0207, Japan.
Hiromi KataokaDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Aichi 467-8602, Japan.
Hirotada NishieDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Aichi 467-8602, Japan.
Yasuhiro FujiwaraDepartment of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Koji OtaniDepartment of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan.
Osamu HandaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Kawasaki Medical School, Okayama 701-0192, Japan.
Yasuhiko MaruyamaDivision of Gastroenterology, Fujieda Municlpal General Hospital, Shizuoka 426-8677, Japan.
Toshio UraokaDepartment of Gastroenterology and Hepatology, Gunma University, Gunma 371-0034, Japan.
Hiroko HosakaDepartment of Gastroenterology and Hepatology, Gunma University, Gunma 371-0034, Japan.
Takahisa FurutaCenter for Clinical Research, Hamamatsu University Hospital, Shizuoka 431-3192, Japan.
Tomohisa TakagiMolecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Masakatsu NakamuraDepartment of Gastroenterology, Kanazawa Medical University, Ishikawa 920-0293, Japan.
Yuya NyumuraDepartment of Surgery, Fuji City General Hospital, Shizuoka 417-8567, Japan.
Akitoshi HakodaSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
Noriaki SugawaraSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
Taro IwatuboEndoscopy Centre, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
Kazuhiro OtaEndoscopy Centre, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
Shinpei KawaguchiSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
Kazuhide HiguchiSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
Hiroki NishikawaSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi Takatsuki, Osaka 569-8686, Japan.
Osaka University of Pharmaceutical Sciences · JPAichi Medical University · JPAkita University · JPAsahikawa Medical University · JPAsahi University · JPDokkyo Medical University · JPFujieda Municipal General Hospital · JPGunma University · JPHyogo University · JPJuntendo University · JPNagoya City University · JPNational Defense Medical College · JPOita University · JPOsaka Metropolitan UniversityAsahikawa Kosei Hospital · JPHamamatsu University Hospital · JPKanazawa Medical University · JPKawasaki Medical School · JPKyoto Prefectural University of Medicine · JPTokyo Medical University Ibaraki Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the trends in idiopathic peptic ulcers, examined the characteristics of refractory idiopathic peptic ulcer, and identified the optimal treatment. The characteristics of 309 patients with idiopathic peptic ulcer were examined. We allocated idiopathic peptic ulcers that did not heal after 8 weeks' treatment (6 weeks for duodenal ulcers) to the refractory group and those that healed within this period to the healed group. The typical risk factors for idiopathic peptic ulcer (atherosclerosis-related underlying disease or liver cirrhosis complications) were absent in 46.6% of patients. Absence of gastric mucosal atrophy (refractory group: 51.4%, healed group: 28.4%;

Indexed as

duodenal ulcersgastric ulcersidiopathic ulcerspotassium-competitive acid blockersrefractoriness

Identifiers

PMID38292123
PMCPMC10822756
OpenAlexW4387868567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.